High expression of CDK5 mRNA has been shown to be associated with adverse metastasis‐free survival in a large study of 456 patients; patient clinicopathological variables and breast cancer‐specific survival were not described, so a direct comparison with the current study cannot be made.18 This evidence concerns the gene CDK5 and breast cancer.